🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH biomarker panel — looking for input Page 4

MASH biomarker panel — looking for input

tammy_FL Wed, Apr 16, 2025 at 3:46 PM 31 replies 2,203 viewsPage 4 of 7
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Apr 24, 2025 at 12:52 PM#16
VanRx_Mike said:
PSA: get baseline labs BEFORE starting baseline bloodwork therapy.

Same experience, arrived at from the opposite direction. Posting only so the count is not one.

Last edited: Apr 24, 2025 at 6:52 PM
8 6mike_mealprep, NicoleRaleigh, james_edin and 5 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Apr 25, 2025 at 7:21 PM#17

Clinical perspective, offered as context rather than as advice. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

9 7mark_tokyo, hans_munich, jason_sac26 and 6 others
Reply Quote Save Share Report
bbq_ray_KC
Member
378
1,678
Jul 2024
Kansas City, KS
Apr 27, 2025 at 1:51 AM#18
julia.endo said:
The useful move here is to separate what is established from what is widely repeated.

Adding a me-too, because a thread of one person's experience is not much use. The detail I would add is minor and it is already implied above.

10 8InsuranceTom, WendyG_ATL, SaraMom3 and 7 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Apr 28, 2025 at 8:22 AM#19
julia.endo said:
The useful move here is to separate what is established from what is widely repeated.

There is a second half to this that has not been said yet. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

That is the short version; the long version is somebody else's post.

Last edited: Apr 28, 2025 at 11:22 AM
11 9lori_vegas, Dr.PulmRoch, maya_sedona and 8 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 29, 2025 at 2:53 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out. Report rather than reply if it drifts again.

33 6PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 30 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register